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INTRODUCTION
Sleep is defined as a naturally recurring state of mind and body, 
characterized by altered consciousness [1], and is divided into two 
types: non-rapid eye movement (non-REM or NREM) and rapid 
eye movement (REM) sleep. Sleep is observed in non-human ani-
mals including mammals, birds, reptiles, amphibians, fish, even in 
insects [2-5] and is required for living animals to live and maintain 
a normal life. It has been growing numbers of sleep disorders: One 
fourth of the general population in America have experienced 
insomnia, one of the most common sleep disorders [6]. Although 
there have been various ways to treat insomnia such as behavioral 
therapy, psychotherapy, and light therapy, the most common one is 
pharmacological treatments using hypnotic drugs targeting GAB-
AA-BZD receptors such as diazepam, zolpidem [7]. However, it has 
been reported that those drugs have many side effects including 
cognitive impairment, tolerance, headache, nausea, and rebound 
insomnia [8, 9]. Therefore, there has been growing need for devel-
oping new hypnotic drugs derived from natural products with less 
side effects. 
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3-Carene, a bicyclic monoterpene, is one of the major components of the pine tree essential oils. It has been reported that, in addition to its known 
properties as a phytoncide, 3-carene has anti-inflammatory, antimicrobial, and anxiolytic effects. We have previously demonstrated that α-pinene, 
the major component of pine tree, has a hypnotic effect through GABAA-benzodiazepine (BZD) receptors. However, a hypnotic effect of 3-carene 
has not been studied yet. Here, we report that oral administration of 3-carene increases the sleep duration and reduces sleep latency in pentobarbi-
tal-induced sleep test. 3-Carene potentiates the GABAA receptor-mediated synaptic responses by prolonging the decay time constant of inhibitory 
synaptic responses. These enhancing effects of 3-carene are reproduced by zolpidem, a modulator for GABAA-BZD receptor, and fully inhibited by 
flumazenil, an antagonist for GABAA-BZD receptor. The molecular docking of 3-carene to the BZD site of GABAA protein structure, suggests that 
3-carene binds to the BZD site of α1 and ϒ2 subunits of GABAA-BZD receptor. These results indicate that, similar to α-pinene, 3-carene shows a 
sleep-enhancing effect by acting as a positive modulator for GABAA-BZD receptor.
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Pines are conifer in the genus Pinus of the family Pinaceae and 
are widely distributed in the forest throughout the world [10, 11]. 
Pines have been widely used for their therapeutic and pharmaco-
logical properties of the volatile essential oils in the Eastern and 
Western World [12-14]. Nowadays, there has been growing interest 
in pine essential oils, also known as phytoncide, for their beneficial 
effects such as enhancing immune systems and relieving stress [15, 
16]. Pine essential oils are mainly consisted of monoterpene such 
as α- and β-pinene, 3-carene, limonene, and terpinene [11]. These 
compounds have various beneficial effects, such as anti-inflamma-
tory, anti-microbial, anti-fungal, and anti-stress [17, 18]. 
3-Carene (3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene) is a bicyclic 
monoterpene consisting of fused cyclohexene and cyclopropane 
rings and has a sweet and pungent odor [19]. It has been used as 
a raw material in perfumes, cosmetics, flavors and terpene resins, 
having various therapeutic properties including anti-inflammato-
ry, anti-fungal, and sedative effects [20, 21]. 3-Carene is the second 
abundant monoterpene of pine essential oils after α-pinene. Re-
cently we have reported a hypnotic effect of α-pinene as a positive 
modulator of GABAA-BZD receptors [22]. Although the beneficial 
effects and biological properties of 3-carene as a phytoncide of 
the pine tree have been established, the potential effect of 3-carene 
on sleep has not been tested yet. In this study, we investigated the 
hypnotic effect of 3-carene in mice by oral administration method. 
We also identified the molecular mechanism of 3-carene through 
the various experimental approaches including electrophysiology, 
pharmacological tools, and molecular modeling. Through our 
previous and current study, we suggest that phytoncides from pine 
trees including α-pinene and 3-carene commonly have sleep-en-
hancing effect as a positive modulator of GABAA-BZD receptors. 
MATERIALS AND METHODS
Materials
3-Carene (CAS no. 13466-78-9) was purchased from Sigma 
Aldrich Inc. (St. Louis, MO, USA). Zolpidem (Ministry of Food 
and Drug Safety, Cheongwon-gun, Chungcheongbuk-do, Korea), 
a GABAA-benzodiazepine (BZD) receptor agonist, was used as 
a reference hypnotic drug. Flumazenil, an antagonist of GABAA-
BZD receptors, was purchased from Sigma-Aldrich Inc. (St. Louis, 
MO, USA). Molecular structures and weights of 3-carene, zolpi-
dem, and flumazenil are shown in Fig. 1. All other chemicals and 
reagents were of the highest grade available.
Animals
All procedures involving animals were conducted in accordance 
with the animal care and use guidelines of the Korea Food Re-
search Institutional Animal Care and Use Committee (permission 
number: KFRI-M-12027). Imprinting control region (ICR; male, 
18~22 g) and C57BL/6N (male 27~30 g) mice were purchased 
from Koatech Animal Inc. (Pyeongtaek, Korea). The animals were 
housed in an insulated, sound-proof recording room maintained 
at an ambient temperature of 23±0.5℃, with a constant relative 
humidity (55±2%) on an automatically controlled 12 h light/12 h 
dark cycle (lights off at 17:00). They had free access to food and 
water. All efforts were made to minimize animal suffering and to 
use only the number of animals required for the production of 
reliable scientific data.
Pentobarbital-induced sleep test
The initial screening for hypnotic effect of 3-carene sleep was 
done with pentobarbital-induced sleep [23]. Experiment was 
performed between 13:00 and 17:00 h, and the ICR mice were 
fasted for 24 h before the experiment to minimize the drowsiness 
induced by food. 3-Carene and zolpidem were administered orally 
(p.o.) to the ICR mice (n=10) 45 min before the pentobarbital in-
jection (45 mg/kg, i.p.). After the injection intraperitoneally (i.p.) of 
pentobarbital, mice were placed in individual cages and observed 
for measurements of sleep latency and duration. The observers 
were blinded to the individual treatments. The mice were consid-
ered asleep if stayed immobile and lost its righting reflex when po-
sitioned on its back. The sleep latency was defined as the elapsed 
time from pentobarbital injection to onset of righting reflex loss. 
The sleep duration was defined as the difference in time between 
Fig. 1.  Chemical structures 
and molecular weight (MW) of 
3-carene, zolpidem and flumaze-
nil.
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the loss and the recovery of the righting reflex. 
Pharmacological treatments
3-Carene was dissolved in sterile saline containing 5% tween 
80 immediately before use, and administered orally (p.o.) to the 
C57BL/6N mice (each group, n=8) at 17:00 h on the experimental 
day at a dose of 12.5, 25, 50, or 100 mg/kg. The positive control 
zolpidem (10 mg/kg) was administered in the same manner as 
3-carene. Flumazenil was dissolved in sterile saline and injected 
intraperitoneally (i.p.) 15 min before 3-carene or zolpidem ad-
ministration. For baseline data, mice were injected with the vehicle 
(saline containing 5% tween 80) at 16:45 h (i.p.) and 17:00 h (p.o.).
Electrophysiological measurement
Adult mice (7~9 weeks) were deeply anaesthetized until ces-
sation of breathing and subsequently decapitated. The brain 
was rapidly removed and submerged in an ice-cold oxygenated 
artificial cerebrospinal fluid (ACSF) composed of (in mM) 130 
NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4, 1 CaCl2, 3 MgCl2, 10 
glucose at pH 7.4, and was bubbled with 5% CO2/95% O2. Trans-
verse mouse brain slices (300 μm) containing hippocampus were 
acutely prepared with a vibratome (Linear slicer, DSK, Japan), and 
incubated in a chamber with oxygenated ACSF at room tempera-
ture for 1 h before use.
The standard ACSF recording solution was composed of (mM): 
130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4, 1.5 CaCl2, 1.5 
MgCl2 and 10 glucose saturated with 95% O2–5% CO2, at pH 
7.4. The internal solution was composed of (mM): 140 CsCl, 10 
EGTA, 10 HEPES, 4 Mg-ATP, 10 QX-314. To block the sponta-
neous EPSC, APV (50 μM; Tocris) and CNQX (20 μM; Tocris) 
were added into ACSF. Recordings were obtained using Axopatch 
200A (Axon instruments, CA, USA) and filtered at 2 kHz. In 
case of sIPSC recording, recordings were digitized at 10 kHz, and 
analyzed using pCLAMP 10 (Molecular devices, CA, USA) and 
Mini Analysis Program (Synaptosoft, NJ, USA). The sIPSCs were 
automatically detected. All experimental procedures described 
were performed in accordance with the institutional guidelines of 
Korea Institute of Science and Technology (KIST, Seoul, Korea).
Molecular modeling
In this study, we used previously published model for the most 
abundant α1β2γ2 subtype of GABAA receptor [22]. 3D coordinates 
of 3-carene was obtained from the PubChem database (https://
pubchem.ncbi.nlm.nih.gov/compound/26049#section=Top). 
Schrodinger 2015 (Schrodinger LLC, New York, NY) package 
was used to perform docking study of 3-carene. Ligand structure 
was imported to the Maestro and prepared using default LigPrep 
setting at 7.4 pH. The putative binding site for docking study was 
considered as benzodiazepine (BZD) site on GABAA, and the 
grid box was assigned to the center of α1Y237, α1H129, α1Y187, 
γ2F116, γ2M169 and γ2T181 residues. We utilized Glide standard 
precision (SP) docking algorithm to dock 3-carene inside receptor, 
and fifty binding poses were generated and ranked according to 
the more negative Glide Gscore value. Gscore function comprises 
of terms for H-bond, hydrophobic, van-der-Waals interaction 
energy, and ligand strain energy. All the figures were rendered us-
ing Discovery Studio Client 2017 R2 package. 3-Carene was map 
on the already developed pharmacophore using Discovery Studio 
to know whether it is an agonist, partial agonist or an antagonist. 
Ligands were taken from the literature to develop pharmacophore 
[24].
Data analysis
All data were expressed as the mean±SEM. Statistical analysis 
was performed with the SigmaPlot 13.0 (Systat Software Inc.). For 
multiple comparisons, data were analyzed using one-way ANOVA 
followed by Dunnett’s test. Comparisons between two-group data 
were analyzed by the unpaired Student’s t-test. The significance 
level was set at p<0.05 for all statistical tests.
RESULTS
Effects of 3-carene in the pentobarbital-induced sleep test
To test whether oral administration (p.o.) of 3-carene (Fig. 1) 
produces a sleep-enhancing effect, we performed the pentobarbi-
tal-induced sleep test in ICR mice (Fig. 2A). As expected, zolpidem 
(10 mg/kg, p.o.), a well-known hypnotic drug and positive modu-
lator of GABAA-BZD receptors [25, 26], significantly decreased 
the sleep latency and increased the sleep duration (sleep latency: 
2.53±0.08 min; sleep duration: 132.1±15.48, Fig. 2B and 2C). We 
found that 3-carene (100 mg/kg, p.o.) also showed a similar effect 
in sleep latency and duration in a dose-dependent manner (sleep 
latency: 2.62±0.05 min; sleep duration: 122.2±8.74, Fig. 2B and 2C) 
as the zolpidem. 
Molecular mechanism of sleep-enhancing effect of 3-carene
Recently we have reported that α-pinene, a monoterpene from 
pine essential oil, acts as a positive modulator of GABAA-BZD re-
ceptor, similarly to other monoterpenes such as borneol, verbenol, 
and pinocarveol [22, 27, 28]. To confirm 3-carene functions like 
these monoterpene, we treated flumazenil, an antagonist of GAB-
AA-BZD receptor, 15 min before administration of 3-carene, and 
then measured the sleep behavior. Flumazenil (1 mg/kg) inhibited 
the hypnotic effect of zolpidem without affecting the sleep latency 
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and duration (Fig. 3B and 3C). The hypnotic effect of 3-carene was 
fully antagonized by flumazenil, suggesting that 3-carene acts as a 
positive modulator of GABAA-BZD receptor, just like zolpidem. 
To confirm that 3-carene is a genuine positive modulator of GA-
BAA-BZD receptor, we performed the conventional slice whole-
cell patch clamp experiments. We measured the inhibitory synaptic 
responses from hippocampal CA1 neurons that express GABAA 
receptors containing α1 and α2 subunits, the well-known targets 
for BZD drugs such as diazepam and zolpidem [29, 30]. We found 
that 3-carene prolonged the decay time constant of spontaneous 
inhibitory postsynaptic currents (sIPSCs) in dose-dependent 
manner (EC50=48.8 nM, Fig. 4B and 4D). This enhancing effect in 
decay time by 3-carene was fully inhibited by flumazenil (1 μM, 
Fig. 4B and 4C). There was no significant difference in frequency 
and amplitude of sIPSCs (Fig. 4E and 4F), consistent with previ-
ous reports [22, 31, 32]. These data suggest that 3-carene enhances 
Fig. 2. (A) Experimental pro-
cedure for sleep test. Effects of 
3-carene on sleep latency (B) and 
sleep duration (C) in mice in-
duced by hypnotic dose (45 mg/
kg, i.p.) of pentobarbital. Each 
column represents mean±SEM 
(n=10). *p<0.05, **p<0.01, signif-
icant as compared to the control 
group (One-way ANOVA, Dun-
nett's test). Con, control group; 
ZPD, zolpidem group.
Fig. 3. (A) Experimental pro-
cedure for sleep test. Effects of 
FLU on the changes in sleep la-
tency (B) and sleep duration (C) 
in mice treated with ZPD and 
3-carene. FLU (8 mg/kg, i.p.) was 
administered 10 min before oral 
administration. Each column 
represents mean±SEM (n=10). 
**p<0.01, significant as com-
pared to the control group (One-
way ANOVA, Dunnett's test). 
##p<0.01, significant between 
FLU treatment and no FLU 
treatment (unpaired Student's t-
test). CON, control group; FLU, 
flumazenil; NS, not significant; 
ZPD, zolpidem group.
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the GABAergic synaptic responses by targeting the GABAA-BZD 
receptor and prolonging the decay time of sIPSCs. 
Docking model of 3-carene in BZD binding site of GABAA 
receptor
Based on the data showing 3-carene acting as a positive modula-
tor of GABAA-BZD receptor, we predicted the binding modes of 
3-carene at the BZD binding site in GABAA receptor through the 
docking and pharmacophore mapping. We found that 3-carene 
binds at BZD site of α1 and γ2 subunits of GABAA receptor with 
-5.39 kcal/mol glide Gscore energy (Fig. 5A and 5B). Docked pose 
reveals that ligand docked in the deep crevice and formed van der 
Waals contact with Ser232, Ser233, Thr234 of α1-subunit, and 
Met168 and Thr181 from γ2-subunit. Phe116 and Tyr97 forms 
pi-pi stacking and pi-sigma interactions with the cyclic ring, and 
7-methyl, respectively (Fig. 5B). This observation coincides with 
the previous report about the importance of these residues in li-
gand interaction identified by modeling and mutagenesis [22, 33-
35]. Also, 3-methyl forms alkyl-alkyl interactions with Ala118 and 
Leu179 of α1- and γ2-subunits, respectively (Fig. 5C). To identify 
the pharmacological class of 3-carene, we mapped 3-carene over 
developed pharmacophore models of agonist, partial agonist, and 
antagonist. We observed that 3-carene only mapped over an an-
tagonist pharmacophore generated by using ZK-93426, APQ2Cl, 
and Ro13-0699 (Fig. 5D). In fact, 3-carene mapped over three 
hydrophobic features but missed two hydrogen bond acceptor 
function. These results indicate that 3-carene positively modulates 
the biological function of GABAA receptor by directly binding at 
the BZD binding site.
DISCUSSION
In this study, we have demonstrated that 3-carene has a sleep-
enhancing effect by prolonging the decay time of GABAergic syn-
aptic response as a positive modulator for GABAA-BZD receptor. 
Although it has been reported that 3-carene has been used as raw 
material in perfumes, cosmetics, flavors, and terpene resins with 
various beneficial effects such as anti-inflammatory, anti-fungal, 
and sedative effects [20, 21], any hypnotic effect of 3-carene has 
not been tested. This is the first study to identify the effect of orally 
administered 3-carene on sleep via the pentobarbital-induced 
sleep test and its molecular mechanism. 
Nowadays there has been growing interest in forest bathing, de-
fined as making contact with and taking in the atmosphere of the 
forest, for its various therapeutic effects such as enhancing immune 
system function, ameliorating respiratory and cardiovascular sys-
Fig. 4. (A) Representative traces of sIPSC before (CON) and after treatment of 3-carene (10 μM). (B) Averaged sIPSCs after normalization by peak. (C) 
Summary bar graph of sIPSC decay value before and after treatment of 3-carene and flumazenil (1 μM, right). ***p<0.001, significant as compared to the 
control group (One-way ANOVA, Dunnett's test). (D~F). Summary graphs of sIPSC decay tau value (D), frequency (E), and amplitude (F) after normal-
ization by control response. Decay response was fitted using sigmoidal logistic 4 parameters.
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tem, relieving stress and anxiety [36, 37]. It has been accepted that 
the various beneficial effects of the forest are due to plant-derived 
products or phytoncide, defined as natural volatile compounds 
derived from trees and plants [37, 38]. The ancient Chinese and 
Korean medicinal literatures have described the therapeutic effects 
of pine tree seeds in digestive function, stress, and sleep and usage 
of pine tree seeds in symptoms or diseases relating to stress and 
sleep [39, 40]. Based on these lines of ancient evidence, we dem-
onstrate the hypnotic effect of phytoncide from pine tree and its 
molecular mechanism through the combination of experimental 
methods including sleep behavior analysis, electrophysiology, and 
molecular modeling. 
We have previously reported that certain purified compounds 
from rice, marine plant, and pine tree all enhance the GABAA 
receptor-mediated synaptic response by prolonging the de-
cay time constant of inhibitory synaptic response by targeting 
GABAA-BZD receptor [22, 23, 32, 41]. We have shown that these 
compounds have hypnotic effects with enhanced quantity of 
non-rapid eye movement sleep (NREMS) [22, 23, 32, 41]. In the 
current study, we found the same effects of 3-carene in IPSCs and 
sleep. Based on these findings, we can make a generalization that 
if a certain drug or compound enhances the decay time constant 
Fig. 5. (A) GABAAR shown by different chain colors. 3-carene (gray sphere) docked inside chain A and chain B (left). (B) Closer view of docked model 
of 3-carene, interacting residues was shown by lines and 3-carene by stick model (upper). 2D-interaction plot of 3-carene and surrounding residues of 
GABAA receptor. (C) Various interactions were represented by distinct color and dashed lines. α1- and γ2-subunit of GABAA receptor is shown by A and 
E chains, respectively. Protein shown by transparent hydrogen bond donor and acceptor surface. Pink and Violet showed Pi-alkyl and pi-sigma interac-
tions. (D) 3-carene mapped over antagonist pharmacophore. Hydrophobic and hydrogen bond acceptor features shown in cyan and green mesh sphere 
(left, middle). Hydrophobic and hydrogen-bond acceptor features were depicted by cyan and green mesh spheres. ZK-93426, Ro13-0699, APQ2Cl and 
3-carene were shown by the red, blue, green and yellow sticks, respectively (right).
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of IPSCs, we can safely predict that it could have a hypnotic effect 
as a positive modulator of GABAA-BZD receptor. Therefore, we 
propose that this electrophysiological assay as a simple screening 
method for finding a potential sleep-enhancing drug. 
In this study, we tested the sleep-enhancing effect of 3-carene 
through pentobarbital-induced sleep test. This method serves as 
a screening tool for finding potential hypnotics and determining 
the proper concentration of drugs for further experiments such 
as electroencephalography (EEG) and electromyography (EMG) 
to examine the effect of 3-carene in sleep stages such as REM 
and non-REM. Therefore, without detailed sleep stage analysis 
with EEG and EMG, there might be a limitation to conclude that 
3-carene has an effect on sleep-wake behavior and sleep archi-
tecture based only on pentobarbital-induced sleep test. However, 
in our previous report on α-pinene [22], we performed all the 
critical experiments including the EEG/EMG and detailed sleep 
stage analysis for α-pinene. In the same previous report, we have 
established that combination of pentobarbital-induced sleep test, 
IPSC recordings, and molecular docking are sufficient to ensure a 
positive effect on sleep stages. Therefore, in the current study with 
3-carene, we did not perform the detailed sleep stage analysis us-
ing EEG and EMG, which takes a lot of effort and time. Instead, we 
believe that the pentobarbital-induced sleep test, IPSC recordings, 
and molecular docking are sufficient to ensure a positive effect of 
3-carene on sleep. Nevertheless, to elucidate the effect of 3-carene 
in sleep stages and architecture, further experiments of EEG and 
EMG with 3-carene are needed in the future. 
Here we have performed the IPSC recordings from hippocampal 
CA1 neurons. The rationale for performing the IPSC recordings 
in hippocampus is that although hippocampus is not the sleep 
control center, it is possible to test the general action of 3-carene in 
hippocampal CA1 neurons expressing GABAA receptors contain-
ing α1 and α2 subunits. These GABAA subunits are the known 
molecular targets for BZD drugs such as diazepam and zolpidem 
[29, 30]. Hippocampal CA1 pyramidal neurons also express GA-
BAA receptors containing α1 and α2 subunits [29], just as the ven-
trolateral preoptic nucleus in the hypothalamus of the actual sleep 
center [42, 43]. The effect of BZD drugs has been tested in neurons 
from various brain regions including thalamus, hippocampus, and 
neocortex [13, 31, 44]. In our previous studies, we have tested the 
effect of various natural compounds on the IPSC decay kinetics in 
hippocampal CA1 neurons and found that the compounds also 
have hypnotic effects [22, 32]. Therefore, testing the effect of can-
didate compounds in the hippocampus CA1 is a convenient and 
simple way for pre-screening for potential hypnotic drugs.
In summary, we have demonstrated that 3-carene as a phyton-
cide from pine tree has the sleep-enhancing effect by targeting 
GABAA-BZD receptor by combining sleep behavior analysis, 
electrophysiology, and molecular modeling. In addition to the 
hypnotic effect of 3-carene, it is known to have other therapeutic 
effects such as anti-inflammatory, anti-oxidant, and anti-stress. We 
can easily obtain these beneficial effects of 3-carene from forest 
bathing, inhalation of pine essential oils, and oral supplements. 
We propose 3-carene as an excellent therapeutic agent for patients 
having sleep disorders or anxiety. 
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